MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 186 filers reported holding MANNKIND CORP in Q3 2014. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $88,000 | +1157.1% | 138,707 | +1204.0% | 0.00% | – |
| Q3 2016 | $7,000 | -46.2% | 10,637 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $13,000 | -50.0% | 10,637 | -43.1% | 0.00% | 0.0% |
| Q1 2016 | $26,000 | +73.3% | 18,692 | +27.2% | 0.00% | 0.0% |
| Q4 2015 | $15,000 | -63.4% | 14,690 | -1.3% | 0.00% | -50.0% |
| Q3 2015 | $41,000 | -48.8% | 14,877 | +3.9% | 0.00% | -50.0% |
| Q2 2015 | $80,000 | +31.1% | 14,314 | +15.7% | 0.00% | 0.0% |
| Q1 2015 | $61,000 | -21.8% | 12,376 | -20.3% | 0.00% | -33.3% |
| Q4 2014 | $78,000 | -22.8% | 15,519 | -8.2% | 0.01% | -25.0% |
| Q3 2014 | $101,000 | -79.2% | 16,906 | -62.0% | 0.01% | -77.8% |
| Q2 2014 | $485,000 | +385.0% | 44,534 | +68.9% | 0.04% | +350.0% |
| Q1 2014 | $100,000 | -46.8% | 26,373 | -27.6% | 0.01% | -46.7% |
| Q4 2013 | $188,000 | +3.3% | 36,412 | +19.6% | 0.02% | +36.4% |
| Q3 2013 | $182,000 | +1.1% | 30,454 | +12.6% | 0.01% | -21.4% |
| Q2 2013 | $180,000 | – | 27,050 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |